CLEVELAND BIOLABS
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.
CLEVELAND BIOLABS
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.cbiolabs.com
Total Employee:
51+
Status:
Active
Contact:
7168496820
Total Funding:
111.1 M USD
Technology used in webpage:
SPF Content Delivery Network ZoneEdit
Current Employees Featured
Founder
Stock Details
Investors List
Norma Investment
Norma Investment investment in Post-IPO Equity - Cleveland BioLabs
David Davidovich
David Davidovich investment in Post-IPO Equity - Cleveland BioLabs
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Cleveland BioLabs
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-12-24 | Panacela Labs | Cleveland BioLabs investment in Series B - Panacela Labs | 2.9 M USD |
| 2011-10-07 | Panacela Labs | Cleveland BioLabs investment in Series A - Panacela Labs | 37 M USD |
Official Site Inspections
http://www.cbiolabs.com
- Host name: 104.21.24.94
- IP address: 104.21.24.94
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
